ArticlePloS one2024

Clinical and economic outcomes of adding [18F]FES PET/CT in estrogen receptor status identification in metastatic and recurrent breast cancer in the US.

Regina Munter-Young et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.